Kiran Mazumdar-Shaw - Director, 10%+ Owner at Bicara Therapeutics Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director, 10%+ Owner
Stock Symbol
BCAX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Kiran Mazumdar-Shaw since 11/5/2023

Holdings reported by Kiran Mazumdar-Shaw for Bicara Therapeutics Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 4.44M Sep 16, 2024 By Biocon Limited
Common Stock 1.08M Sep 16, 2024 By Biocon Pharma Inc.
Common Stock 433K Sep 16, 2024 By Carica Investments
Common Stock 325K Sep 16, 2024 By Glentech International
Stock Option (Right to Buy) 23.7K Sep 12, 2024 Direct Common Stock
Series Seed Redeemable Convertible Preferred Stock 0 Sep 16, 2024 By Biocon Limited Common Stock
Series Seed Redeemable Convertible Preferred Stock 0 Sep 16, 2024 By Biocon Pharma Inc. Common Stock
Series Seed Redeemable Convertible Preferred Stock 0 Sep 16, 2024 By Carica Investments Common Stock
Series Seed Redeemable Convertible Preferred Stock 0 Sep 16, 2024 By Glentech International Common Stock

Transactions reported by Kiran Mazumdar-Shaw for Bicara Therapeutics Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.